Results and discussion
Alternative splicing of the α-dystrobrevin gene in skeletal and cardiac muscle generates three isoforms (α-dystrobrevin-1, -2 and -3) of which only the two larger isoforms α1 and α2 contain the syntrophin-and dystrophin-binding sites [6] (Figure 1a) . α-Dystrobrevin-1 and -2 are also subject to further alternative splicing in skeletal and cardiac muscle, resulting in the expression of two additional exons before the coiled-coil domain. The function of these additional 57 amino acids, termed the vr3 sequence in mouse, has not been described ( Figure 1a ).
To identify binding partners for the vr3 sequence of α-dystrobrevin, a yeast two-hybrid screen was performed using the alternatively spliced exons 12 and 13 as a 'bait' (Figure 1a ). This vr3 bait, which also contained 16 residues of common α-dystrobrevin flanking sequence, was screened against a cDNA library generated from cultured H2K myotubes. Approximately 3 million clones were screened and of the 28 vr3 interactors identified, 18 clones encoded β1-syntrophin and 6 encoded α-syntrophin. This implies that the vr3 sequence binds syntrophin. Biochemical and yeast two-hybrid studies have previously been published with the aim of defining the syntrophinbinding site on dystrobrevin and dystrophin [7] [8] [9] [10] [11] . Although there were some discrepancies, these reports all argued that the syntrophin-binding site was located upstream of the first coiled-coil domain of both dystrobrevin and dystrophin ( Figure 1a) . Thus, the data from our yeast two-hybrid screen indicates that the vr3 sequence provides a second syntrophin-binding site in skeletal and cardiac muscle.
To test the hypothesis that the vr3 sequence provides a second syntrophin-binding site on α-dystrobrevin, we generated a series of new α-dystrobrevin bait constructs and tested their ability to interact with α and β1 syntrophins in the yeast two-hybrid system (Figure 1a ). The vr3 sequence was separated into its constituent exons 12 and 13, and a new vr3 bait was generated that did not contain any common α-dystrobrevin flanking sequence (exons 12 + 13, Figure 1a ). Finally, we constructed a bait encompassing the previously characterised syntrophinbinding site of exon 14 together with the first coiled-coil domain (exon 14 + cc1, Figure 1a ). Co-transformed yeast were tested for expression of β-galactosidase and growth on histidine-deficient media. As Figure 1b illustrates, exon 12 of the vr3 sequence does not interact with either of the syntrophins, whereas both exon 13 and exon 14 + ccI baits clearly interact, thus confirming the existence of two distinct syntrophin-binding sites on α-dystrobrevin.
Sequence analysis of the syntrophin-binding region of α-dystrobrevin identifies a previously undescribed tandem pair of predicted α helices, one in the vr3 exon 13 and the other in exon 14. These α helices are similar to each other and each helix is predicted to form a syntrophin-binding motif. These tandem helices are not only found in α-dystrobrevin, but also in the other members of the dystrophin family of proteins, including utrophin ( Figure 2 ). The sequence similarity between the pair of tandem syntrophin-binding motifs is most apparent for β-dystrobrevin [12, 13] . Self-comparison of human β-dystrobrevin (GenBank identifier 2935183) using MACAW [14] and PROSPERO [15] revealed significant sequence similarity (p = 1.4 × 10 -4 and 5.6 × 10 -6 , for the two methods respectively) between the two repeats. As the dystrobrevins, dystrophins and utrophins can be aligned accurately throughout their carboxy-terminal regions, it can be inferred from the pair of sequence-similar motifs in dystrobrevins that all other dystrophin-related molecules also possess such syntrophin-binding sites. The exception is the sequence of C. elegans DYS-1, for which no syntrophinbinding motif repeats could be found. In summary, the skeletal muscle DPC has four syntrophin-binding motifs: two located in α-dystrobrevin and two in dystrophin.
To confirm that the predicted syntrophin-binding motif of dystrobrevin is able to bind syntrophin, a minimal peptide encompassing this region was synthesised and chemically linked to an affinity matrix. The immobilised peptide was incubated with mouse brain or skeletal muscle extracts and the bound proteins were eluted. As Figure 3 shows, western blots of these eluates demonstrated the specific binding of syntrophin to the syntrophin-binding motif (a) Schematic representation of the α-dystrobrevin isoforms in muscle. The identifiable domains are boxed: EF, EF hand region, predicted calcium-binding domain; ZZ, ZZ domain, putative zinc-binding domain; vr3, variable region 3; cc, coiled-coil domain [23] ; Y, unique tyrosine kinase substrate domain of α-dystrobrevin-1. The location of the previously identified dystrophin-binding site (DBS) [23, 24] and syntrophin-binding site (SBS) [7] [8] [9] [10] [11] are indicated by blue lines. The red lines indicate the yeast two-hybrid bait constructs generated for defining the syntrophin-binding sites on α-dystrobrevin. (b) Evidence for two syntrophin-binding sites on α-dystrobrevin in skeletal and cardiac muscle. β-Galactosidase filter assays were performed on yeast co-transformed with the bait and prey constructs indicated. All baits were co-transformed with the empty prey vector pYesTrp2 to confirm that these constructs do not nonspecifically activate the lacZ and HIS3 reporter genes. Exon 12 of the vr3 sequence does not interact with α1-or β1-syntrophin preys as indicated by the pink yeast. Vr3 exon 13 and exon 14 + cc1 baits both interact with syntrophin as shown by the production of β-galactosidase. Negative controls: empty bait vector (pHybLex/Zeo) co-transformed with empty prey vector (pYesTrp2). Positive control: full-length β-dystrobrevin bait in pHybLex/Zeo cotransformed with α1-syntrophin prey in pYesTrp2 (M. 
Figure 2
A multiple sequence alignment of the tandem syntrophin-binding motifs, coloured using CHROMA (http://www.lg.ndirect.co.uk/chroma/) and a consensus sequence calculated at a 75% level. Aliphatic (l) residues or big (b) residues are grey on yellow; hydrophobic (h) residues black on yellow; polar (p) residues blue; small (s) residues dark green; tiny (t) residues in light green; negatively charged (-) residues in red; and amino acids conserved in >75% of sequences are yellow on black. peptide (SBM-PEP), but not to a control dystrobrevin peptide (DB-PEP), nor to the affinity matrix (NO-PEP). This confirms the physiological relevance of the predicted dystrobrevin-syntrophin interaction.
Since the pioneering identification of dystrophin, an extensive literature has accumulated on the function and binding partners of this protein (for review, see [16, 17] ). Despite this wealth of knowledge, very little is known about the mechanisms and sequences that are required for building the DPC. The present study not only provides the sequence basis for syntrophin binding to the DPC but also shows that alternative splicing offers a mechanism for regulating the number of syntrophin-binding sites within a given complex.
Alternative splicing is not only used by α-dystrobrevin to regulate the stoichiometry of syntrophin binding. Dystrophin is also alternatively spliced in the syntrophinbinding region in brain, heart and skeletal muscle, generating further flexibility in the number of syntrophin molecules that can associate with the DPC [18, 19] . Alternative splicing of dystrophin exons 71-74 in brain can result in the removal of both syntrophin-binding motifs. Moreover, regulating the stoichiometry of binding partners using alternative splicing is likely to be a prominent mechanism in modulating the signalling functions of other large intracellular complexes.
The consequence of this flexibility in the number of syntrophin binding sites is likely to be reflected in the cellular function of a particular dystrophin complex. In skeletal muscle, the existence of four syntrophin-binding motifs per DPC, which in theory may be occupied by any combination of four syntrophins (α, β1, β2 and γ2) [3, 20] , generates the potential for specialised complexes at different locations and developmental stages (Figure 4 ). This may be of particular importance in generating specific signalling complexes in synaptic versus extrasynaptic regions of skeletal muscle fibres. Indeed, it is well documented that the localisation of β2-syntrophin is restricted to the postsynaptic membrane of the neuromuscular junction [21] , whereas β1-syntrophin expression is largely limited to the sarcolemma of a subset of fast-twitch muscle fibres (type IIB) [3] . Although the specificity of each syntrophinbinding motif for a particular syntrophin is unknown, the regulation of the number of syntrophin-binding sites coupled with the extensive list of syntrophin-associated proteins [4, [25] [26] [27] [28] is likely to be important in the construction of specialised signalling complexes in muscle and other tissues.
Materials and methods

H2K myotube cDNA library
H2K myoblasts [22] were differentiated in culture for 7 days into myotubes before extraction of poly(A) + RNA using FastTrack 2.0 (Invitrogen). cDNA was generated as described previously [5] . Bst XI/EcoRI adaptors were ligated onto cDNA ends and subsequently cloned into the prey vector pYesTrp2 (Invitrogen).
Brief Communication 1297
Figure 3
The syntrophin-binding motif of dystrobrevin binds syntrophin. The western blot shown was probed with the pansyntrophin antibody SYN1351 and demonstrates the specific purification of syntrophin from brain extracts using an immobilised peptide corresponding to the syntrophin-binding motif of dystrobrevin ( Revised model of the dystrophin protein complex in skeletal muscle. 
Yeast two-hybrid analysis
All methods for yeast two-hybrid screening are described in the Hybrid Hunter instruction manual (Invitrogen). The following α-dystrobrevin baits were generated by PCR using the following primer sets and cloned into the vector pHybLex/Zeo (Invitrogen): vr3 (forward: 5′-CAGAATTCTCAGGAAGTCCTTTCATCAC; reverse: 5′-CACTGA-GTCACCGGTTTGAACTCTCA), exon 12 (forward: 5′-CAGAATTCT-CTCCTCCCAAGGACAGTGA; reverse: 5'-CACTCGAGTCACCCT-CTGCCCTTCAGAAA), exon 13 (forward: 5′-CAGAATTCGGGATAC-AGTACAGCCTGAA; reverse: 5′-CACTCGAGTCATGGTGGGTTGT-TCCGGA), exon 12 and 13 (exon 12 forward primer and exon 13 reverse primer), exon 14 and HI (forward: 5′-CAGAATTCATGCTTGA-GAGTTCAAACCGG; reverse: 5′-CACTCGAGTCAGGGCTGGGA-AGCTTGCT). The α-and β1-syntrophin preys were identified by screening the H2K cDNA library with the vr3 bait. The β1-syntrophin clone corresponds to nucleotides 1133-2158 (GenBank identifier 7710095) and the α-syntrophin clone corresponds to nucleotides 250-2012 (GenBank identifier 6678056). The yeast strain L40 was transformed with appropriate baits and preys as indicated in Figure 1 . Individual co-transformants were streaked onto selective plates to test for growth in the absence of histidine and onto permissive plates for β-galactosidase filter assays.
Peptide affinity chromotography
The syntrophin-binding motif peptide (SBM-PEP: NH 2 -RLDEE-HRLI-ARYAARLAC) and a control dystrobrevin peptide (DB-PEP: NH 2 -CTGS-PHTSPTHGGGRPM) were chemically coupled to SulfoLink Coulping Gel (Pierce) according to the manufacturer's instructions. Two hundred microlitres of coupled SulfoLink gel was incubated overnight at 4°C with 2 mg of mouse brain or skeletal muscle extracted in RIPA buffer (150 mM NaCl, 1% v/v Triton X-100, 0.5% w/v sodium deoxycholate, 0.1% w/v SDS, 50 mM Tris pH 8.0) supplemented with protease inhibitors (Sigma). The gel was washed extensively with RIPA buffer and eluted in treatment buffer (3.8% w/v SDS, 4 M urea, 5% v/v β-mercaptoethanol, 20% v/v glycerol, 75 mM Tris pH 6.8). Samples were run on 10% polyacrylamide gels and western blotted according to standard methods. Blots were probed with the pansyntrophin monoclonal antibody SYN1351 and developed using the BM chemiluminescence substrate system (Boehringer Mannheim).
